TRIPLE NEGATIVE

Clinical trials for TRIPLE NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new TRIPLE NEGATIVE trials appear

Sign up with your email to follow new studies for TRIPLE NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo aims to wipe out hidden breast cancer cells

Disease control Recruiting now

This study tests a new drug combination (sarilumab plus capecitabine) in people with aggressive breast cancer that has not responded fully to standard treatment. The goal is to eliminate any remaining cancer cells that could cause the disease to spread. The trial involves 65 adul…

Matched conditions: TRIPLE NEGATIVE

Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control

Last updated May 01, 2026 15:59 UTC

TRIPLE NEGATIVE

Get alerted when new TRIPLE NEGATIVE trials appear

New combo aims to wipe out hidden breast cancer cells